HITI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
High Tide Inc (HITI) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown strong revenue growth and positive developments in the medical cannabis market, the stock's technical indicators are bearish, and there are no strong trading signals or significant positive catalysts to suggest immediate upside potential. Holding off for now is recommended.
The MACD is slightly positive but contracting, indicating weak momentum. RSI is neutral at 45.17, showing no clear trend. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading below its pivot level of 2.407, with key support at 2.251 and resistance at 2.564. Overall, the technical outlook is bearish.
Record revenue of $179.3 million in Q2 FY2026, a 30% YoY increase.
Strong performance in the medical cannabis market, particularly in Germany, through its subsidiary Remexian.
Positive news coverage highlighting growth opportunities and expanding product portfolio.
Recent price performance is weak, with a -2.53% decline in the regular market session and bearish technical indicators.
No significant hedge fund or insider trading trends.
Stock trend analysis suggests a likelihood of further short-term declines (-0.93% next day, -0.91% next week, -4.01% next month).
High Tide reported record revenue of $179.3 million in Q2 FY2026, reflecting a 30% year-over-year increase. Its subsidiary Remexian Pharma GmbH also achieved record revenue of $31.6 million in the same quarter, indicating strong growth in the medical cannabis market.
No recent analyst rating or price target changes were provided. Wall Street sentiment appears neutral with no significant pros or cons highlighted.
